Saturday 17 October 2026 Export HCAT’s income statement to Excel — free account

Health Catalyst, Inc.

HCAT Healthcare Health Information Services

Health Catalyst, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $311.1 million, up 1.48% from fiscal 2024. In the quarter to June 2026, revenue fell 12.7%, EPS grew 6.78%, free cash flow grew 64.3% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.

1.73 0.07 −3.89%

Follow HCAT

Alert me

Market cap: $135.5M
P/E: 0.0×
Fwd P/E: −0.9×
Dividend yield: —
F-score: 5/9
Altman Z: −3.66
Beneish M: −3.95
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total buys 0.11

Total sells 0.20

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	1	—
Sell	—	2	—	—	—	—	—	—	—	—	—	—

Insider Ownership 20.42%

Capital & Financial Ratios $m

Market Cap 135.47

Revenue 292.25

Net Income (264.82)

Free Cash Flow 6.59

Net Debt 50.04

Current Ratio 2.70

Debt/Equity 1.52

P/E ratio 0.00

Fwd P/E (0.93)

P/S ratio 0.44

P/B ratio 1.27

Past 5Y EPS Growth —

This Y EPS Growth (119.99%)

Next Y EPS Growth 122.45%

Next Y revenue growth (20.36%)

Next 5Y EPS Growth (10.28%)

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 6.38%

10-year low 10-year high

P/B against its own 10 years 35.67%

10-year low 10-year high

EV/Sales against its own 10 years 6.43%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2025	Powerpack
2024	Powerpack
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack
2019	Powerpack
2018	Powerpack

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	318	392	96	103
Receivables	60	57	59	42
Inventory	—	—	—	—
Other	—	—	—	91
	393	466	169	248

	2023	2024	2025	Q'26
Payables	7	11	9	8
ST’ Debt	—	231	2	2
Other	—	—	—	12
	89	326	90	92

Compound Annual Growth %

	10y	5y	3y
Sales	—	10.50%	4.05%
Cash Flow	—	0.00%	0.00%
Earnings	—	0.00%	0.00%
Book Value	—	(2.30%)	(16.69%)

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	71	70	—	—	—
’25	79	81	76	75	311
’24	75	76	76	80	307
’23	74	73	74	75	296
’22	68	71	68	69	276
’21	56	60	62	65	242
’20	45	43	47	53	189

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	19	0	—	—	—
’25	0	(9)	0	10	1
’24	10	2	6	(4)	15
’23	(6)	(12)	3	(19)	(33)
’22	1	(10)	(12)	(15)	(35)
’21	(3)	(5)	(5)	(10)	(23)
’20	(17)	(1)	(4)	(4)	(26)

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	13	(5)	—	—	—
’25	(5)	(14)	(6)	4	(21)
’24	7	(3)	2	(8)	(2)
’23	(9)	(16)	0	(22)	(47)
’22	(3)	(14)	(16)	(326)	(359)
’21	(10)	(8)	(9)	(14)	(42)
’20	(18)	(2)	(6)	(11)	(37)

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(1.53)	(0.55)	—	—	—
’25	(0.35)	(0.59)	(0.32)	(1.28)	(2.55)
’24	(0.35)	(0.23)	(0.24)	(0.33)	(1.15)
’23	(0.60)	(0.58)	(0.39)	(0.53)	(2.09)
’22	(0.42)	(0.62)	(0.84)	(0.66)	(2.63)
’21	(0.65)	(0.80)	(0.82)	(0.94)	(3.23)
’20	(0.47)	(0.71)	(0.68)	(1.01)	(2.91)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	—	—	—	26.00	17.48	35.96	6.40	6.60	5.42	2.02	Analyst estimates 2026–2028 Powerpack
	High	—	—	—	49.85	45.56	59.50	40.65	15.87	11.41	7.65
People
People	Employees	—	—	728	900	1,000	1,200	1,200	1,300	1,500	1,200
	Revenue/emp, $m	—	0.00	0.15	0.17	0.19	0.20	0.23	0.23	0.20	0.26
Income, $m
Income, $m	Revenue	—	73	113	155	189	242	276	296	307	311
	Gross margin, %	—	40.28	46.83	51.37	48.06	48.60	48.21	44.55	45.92	48.75
	EBT	—	(47)	(62)	(60)	(116)	(160)	(142)	(118)	(69)	(177)
	EBT margin, %	—	(64.32)	(55.18)	(38.69)	(61.54)	(66.18)	(51.29)	(39.80)	(22.56)	(56.97)
	Net income	—	(47)	(62)	(60)	(115)	(153)	(137)	(118)	(70)	(178)
	Depreciation	—	6	8	10	27	49	50	44	45	164
Per share, $
Per share, $	Revenue	—	15.08	23.46	8.27	4.78	5.09	5.14	5.25	5.09	4.45
	Earnings	—	(9.70)	(12.92)	(12.86)	(2.91)	(3.23)	(2.56)	(2.09)	(1.15)	(2.55)
	Cash flow	—	(7.60)	(8.40)	(1.72)	(0.66)	(0.49)	(0.66)	(0.59)	0.24	0.01
	Capex	—	(0.68)	(0.52)	(0.23)	(0.26)	(0.39)	(6.03)	(0.25)	(0.27)	(0.31)
	Free cash flow	—	(8.28)	(8.91)	(1.95)	(0.93)	(0.88)	(6.69)	(0.84)	(0.03)	(0.30)
	Book value	—	0.00	(78.11)	10.71	6.98	10.99	7.91	6.50	6.07	3.52
	Shares, m	—	5	5	19	40	47	54	56	60	70
Valuation, ×
Valuation, ×	P/E	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	P/S	—	0.00	0.00	4.20	9.11	7.78	2.02	1.74	1.39	0.54
	P/B	—	0.00	0.00	3.24	6.23	3.60	1.31	1.40	1.17	0.68
	EV/Sales	—	0.00	0.00	3.05	8.59	6.70	1.54	1.45	1.36	0.72
	EV/FCF	—	(3.30)	(3.30)	(12.98)	(44.32)	(39.00)	(1.18)	(9.04)	(227.75)	(10.81)
Cash, $m
Cash, $m	Operating cash flow	—	(37)	(40)	(32)	(26)	(23)	(35)	(33)	15	1
	Capex	—	(3)	(2)	(4)	(10)	(18)	(324)	(14)	(16)	(22)
	Free cash flow	—	(40)	(43)	(36)	(37)	(42)	(359)	(47)	(2)	(21)
Balance, $m
Balance, $m	Working capital	—	40	25	216	242	415	345	304	140	80
	Total debt	—	13	20	51	172	184	230	228	382	153
	Net debt	—	(39)	(13)	(177)	(99)	(261)	(134)	(90)	(10)	58
	Shareholders’ equity	—	—	(375)	201	276	522	425	367	365	246
Returns, %
Returns, %	ROA	—	(53.14)	(205.49)	(116.57)	(26.14)	(21.73)	(17.34)	(16.25)	(8.91)	(26.14)
	ROIC	—	0.00	0.00	(146.71)	(33.97)	(34.34)	(30.02)	(28.61)	(12.27)	(33.15)
	ROE	—	18.54	35.95	276.72	(48.25)	(38.39)	(29.02)	(29.84)	(18.99)	(58.26)

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
CSLT Castlight Health, inc.	$332.4M	— (loss-making)	— (loss-making)	−0.86% (below 0%: shrinking)	n/m	+106.49% (above 0%: growing)	66.20%	(5.42%)	Compare
SPOK Spok Holdings, Inc.	$224.5M	17.7×	16.2×	−1.89% (below 0%: shrinking)	−9.09% (below 0%: shrinking)	−2.00% (below 0%: shrinking)	80.47%	15.50%	Compare
AMWL American Well Corporation	$210.6M	— (loss-making)	— (loss-making)	−26.59% (below 0%: shrinking)	n/m	+266.38% (above 0%: growing)	52.95%	(18.36%)	Compare
SY So-Young International Inc. Sponsored ADR	$198.9M	— (loss-making)	12.8×	+40.84% (above 0%: growing)	n/m	−798.37% (below 0%: shrinking)	44.11%	(8.64%)	Compare
OPRX OptimizeRx Corp.	$166.7M	35.4×	23.0×	−29.77% (below 0%: shrinking)	n/m	+89.86% (above 0%: growing)	76.51%	(0.43%)	Compare
DH Definitive Healthcare Corp.	$144.3M	— (loss-making)	— (loss-making)	−9.14% (below 0%: shrinking)	n/m	+21.44% (above 0%: growing)	73.45%	(12.23%)	Compare
HCAT Health Catalyst, Inc.	$135.5M	— (loss-making)	— (loss-making)	−12.68% (below 0%: shrinking)	n/m	+64.26% (above 0%: growing)	49.46%	(51.75%)
LFMD LifeMD, Inc.	$118.6M	— (loss-making)	— (loss-making)	−3.55% (below 0%: shrinking)	n/m	−247.52% (below 0%: shrinking)	88.82%	(15.08%)	Compare
CCLD CareCloud, Inc.	$82.0M	26.4×	12.5×	+16.45% (above 0%: growing)	n/m	+6.15% (above 0%: growing)	45.24%	5.84%	Compare
Median of peers	$182.8M	26.4×	14.5×	−2.72%	—	+13.80%	69.83%	(7.03%)

All 51 Health Information Services stocks →

Health Catalyst, Inc. (HCAT) key facts

Strength: Health Catalyst, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $311.1 million, up 1.48% from fiscal 2024.
Health Catalyst, Inc. (HCAT) is a Health Information Services company in the Healthcare sector, listed on Nasdaq.
As of October 16, 2026, HCAT traded at $1.73, a market capitalization of $135.5 million.
Return on equity was −58.3% and debt-to-equity 1.52.
Its Piotroski F-score is 5 out of 9 and its Altman Z-score is −3.66 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.